Global Transplantation Therapeutics Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: GCA777791F14EN
QYResearch

Abstracts

This report focuses on the global Transplantation Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transplantation Therapeutics Drugs development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Novartis
• GlaxoSmithKline
• AbbVie
• Pfizer
• Astellas Pharma
• Gilead Sciences
• SBI Biotech
• Sanofi
• Takeda

Market segment by Type, the product can be split into

• Calcineurin Inhibitors
• Anti-Proliferative Agents
• Corticosteroids
• Others

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Transplantation Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Transplantation Therapeutics Drugs development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Transplantation Therapeutics Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transplantation Therapeutics Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Transplantation Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Calcineurin Inhibitors
  1.4.3 Anti-Proliferative Agents
  1.4.4 Corticosteroids
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Transplantation Therapeutics Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Transplantation Therapeutics Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Transplantation Therapeutics Drugs Industry
    1.6.1.1 Transplantation Therapeutics Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Transplantation Therapeutics Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Transplantation Therapeutics Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Transplantation Therapeutics Drugs Market Perspective (2015-2026)
2.2 Transplantation Therapeutics Drugs Growth Trends by Regions
  2.2.1 Transplantation Therapeutics Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Transplantation Therapeutics Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Transplantation Therapeutics Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Transplantation Therapeutics Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Transplantation Therapeutics Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Transplantation Therapeutics Drugs Players by Market Size
  3.1.1 Global Top Transplantation Therapeutics Drugs Players by Revenue (2015-2020)
  3.1.2 Global Transplantation Therapeutics Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Transplantation Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transplantation Therapeutics Drugs Market Concentration Ratio
  3.2.1 Global Transplantation Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Transplantation Therapeutics Drugs Revenue in 2019
3.3 Transplantation Therapeutics Drugs Key Players Head office and Area Served
3.4 Key Players Transplantation Therapeutics Drugs Product Solution and Service
3.5 Date of Enter into Transplantation Therapeutics Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Transplantation Therapeutics Drugs Historic Market Size by Type (2015-2020)
4.2 Global Transplantation Therapeutics Drugs Forecasted Market Size by Type (2021-2026)

5 TRANSPLANTATION THERAPEUTICS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Transplantation Therapeutics Drugs Market Size by Application (2015-2020)
5.2 Global Transplantation Therapeutics Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Transplantation Therapeutics Drugs Market Size (2015-2020)
6.2 Transplantation Therapeutics Drugs Key Players in North America (2019-2020)
6.3 North America Transplantation Therapeutics Drugs Market Size by Type (2015-2020)
6.4 North America Transplantation Therapeutics Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Transplantation Therapeutics Drugs Market Size (2015-2020)
7.2 Transplantation Therapeutics Drugs Key Players in Europe (2019-2020)
7.3 Europe Transplantation Therapeutics Drugs Market Size by Type (2015-2020)
7.4 Europe Transplantation Therapeutics Drugs Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Transplantation Therapeutics Drugs Market Size (2015-2020)
8.2 Transplantation Therapeutics Drugs Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2015-2020)
8.4 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Novartis
  9.1.1 Novartis Company Details
  9.1.2 Novartis Business Overview and Its Total Revenue
  9.1.3 Novartis Transplantation Therapeutics Drugs Introduction
  9.1.4 Novartis Revenue in Transplantation Therapeutics Drugs Business (2015-2020))
  9.1.5 Novartis Recent Development
9.2 GlaxoSmithKline
  9.2.1 GlaxoSmithKline Company Details
  9.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Introduction
  9.2.4 GlaxoSmithKline Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.2.5 GlaxoSmithKline Recent Development
9.3 AbbVie
  9.3.1 AbbVie Company Details
  9.3.2 AbbVie Business Overview and Its Total Revenue
  9.3.3 AbbVie Transplantation Therapeutics Drugs Introduction
  9.3.4 AbbVie Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.3.5 AbbVie Recent Development
9.4 Pfizer
  9.4.1 Pfizer Company Details
  9.4.2 Pfizer Business Overview and Its Total Revenue
  9.4.3 Pfizer Transplantation Therapeutics Drugs Introduction
  9.4.4 Pfizer Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.4.5 Pfizer Recent Development
9.5 Astellas Pharma
  9.5.1 Astellas Pharma Company Details
  9.5.2 Astellas Pharma Business Overview and Its Total Revenue
  9.5.3 Astellas Pharma Transplantation Therapeutics Drugs Introduction
  9.5.4 Astellas Pharma Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.5.5 Astellas Pharma Recent Development
9.6 Gilead Sciences
  9.6.1 Gilead Sciences Company Details
  9.6.2 Gilead Sciences Business Overview and Its Total Revenue
  9.6.3 Gilead Sciences Transplantation Therapeutics Drugs Introduction
  9.6.4 Gilead Sciences Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.6.5 Gilead Sciences Recent Development
9.7 SBI Biotech
  9.7.1 SBI Biotech Company Details
  9.7.2 SBI Biotech Business Overview and Its Total Revenue
  9.7.3 SBI Biotech Transplantation Therapeutics Drugs Introduction
  9.7.4 SBI Biotech Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.7.5 SBI Biotech Recent Development
9.8 Sanofi
  9.8.1 Sanofi Company Details
  9.8.2 Sanofi Business Overview and Its Total Revenue
  9.8.3 Sanofi Transplantation Therapeutics Drugs Introduction
  9.8.4 Sanofi Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.8.5 Sanofi Recent Development
9.9 Takeda
  9.9.1 Takeda Company Details
  9.9.2 Takeda Business Overview and Its Total Revenue
  9.9.3 Takeda Transplantation Therapeutics Drugs Introduction
  9.9.4 Takeda Revenue in Transplantation Therapeutics Drugs Business (2015-2020)
  9.9.5 Takeda Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Transplantation Therapeutics Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Transplantation Therapeutics Drugs Revenue
Table 3. Ranking of Global Top Transplantation Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transplantation Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Calcineurin Inhibitors
Table 6. Key Players of Anti-Proliferative Agents
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Transplantation Therapeutics Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Transplantation Therapeutics Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Transplantation Therapeutics Drugs Players to Combat Covid-19 Impact
Table 14. Global Transplantation Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Transplantation Therapeutics Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Transplantation Therapeutics Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Transplantation Therapeutics Drugs Market Share by Regions (2015-2020)
Table 18. Global Transplantation Therapeutics Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Transplantation Therapeutics Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Transplantation Therapeutics Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Transplantation Therapeutics Drugs Players
Table 25. Global Transplantation Therapeutics Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Transplantation Therapeutics Drugs Market Share by Players (2015-2020)
Table 27. Global Top Transplantation Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation Therapeutics Drugs as of 2019)
Table 28. Global Transplantation Therapeutics Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Transplantation Therapeutics Drugs Product Solution and Service
Table 31. Date of Enter into Transplantation Therapeutics Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Transplantation Therapeutics Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Transplantation Therapeutics Drugs Market Size Share by Type (2015-2020)
Table 35. Global Transplantation Therapeutics Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Transplantation Therapeutics Drugs Market Size Share by Application (2015-2020)
Table 37. Global Transplantation Therapeutics Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Transplantation Therapeutics Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Transplantation Therapeutics Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Transplantation Therapeutics Drugs Market Share (2019-2020)
Table 41. North America Transplantation Therapeutics Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Transplantation Therapeutics Drugs Market Share by Type (2015-2020)
Table 43. North America Transplantation Therapeutics Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Transplantation Therapeutics Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Transplantation Therapeutics Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Transplantation Therapeutics Drugs Market Share (2019-2020)
Table 47. Europe Transplantation Therapeutics Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Transplantation Therapeutics Drugs Market Share by Type (2015-2020)
Table 49. Europe Transplantation Therapeutics Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Transplantation Therapeutics Drugs Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Transplantation Therapeutics Drugs Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Transplantation Therapeutics Drugs Market Share (2019-2020)
Table 53. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Transplantation Therapeutics Drugs Market Share by Type (2015-2020)
Table 55. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Transplantation Therapeutics Drugs Market Share by Application (2015-2020)
Table 57. Novartis Company Details
Table 58. Novartis Business Overview
Table 59. Novartis Product
Table 60. Novartis Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 61. Novartis Recent Development
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Product
Table 65. GlaxoSmithKline Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 66. GlaxoSmithKline Recent Development
Table 67. AbbVie Company Details
Table 68. AbbVie Business Overview
Table 69. AbbVie Product
Table 70. AbbVie Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 71. AbbVie Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Product
Table 75. Pfizer Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 76. Pfizer Recent Development
Table 77. Astellas Pharma Company Details
Table 78. Astellas Pharma Business Overview
Table 79. Astellas Pharma Product
Table 80. Astellas Pharma Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 81. Astellas Pharma Recent Development
Table 82. Gilead Sciences Company Details
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Product
Table 85. Gilead Sciences Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 86. Gilead Sciences Recent Development
Table 87. SBI Biotech Company Details
Table 88. SBI Biotech Business Overview
Table 89. SBI Biotech Product
Table 90. SBI Biotech Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 91. SBI Biotech Recent Development
Table 92. Sanofi Business Overview
Table 93. Sanofi Product
Table 94. Sanofi Company Details
Table 95. Sanofi Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 96. Sanofi Recent Development
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Product
Table 100. Takeda Revenue in Transplantation Therapeutics Drugs Business (2015-2020) (Million US$)
Table 101. Takeda Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Transplantation Therapeutics Drugs Market Share by Type: 2020 VS 2026
Figure 2. Calcineurin Inhibitors Features
Figure 3. Anti-Proliferative Agents Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Transplantation Therapeutics Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Transplantation Therapeutics Drugs Report Years Considered
Figure 11. Global Transplantation Therapeutics Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transplantation Therapeutics Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Transplantation Therapeutics Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transplantation Therapeutics Drugs Market Share by Players in 2019
Figure 16. Global Top Transplantation Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation Therapeutics Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transplantation Therapeutics Drugs Revenue in 2019
Figure 18. North America Transplantation Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transplantation Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Transplantation Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Novartis Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AbbVie Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 29. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Astellas Pharma Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 31. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Gilead Sciences Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 33. SBI Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. SBI Biotech Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sanofi Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 37. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed